The difficulties of working with radiotracers

ESMO 2017 highlights on managing difficult to treat cancers

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Pembrolizumab falls short of endpoints in KEYNOTE 40

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

Initial results of inhibitor combination against breast and gynaecologic cancers

Patient empowerment and quality of life

Chemoradiation remains best treatment for locally advanced cervical cancer

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Fertility-preserving procedures in BRCA mutation-positive breast cancer

Nivolumab and ipilimumab for metastatic kidney cancer